CI Financial (TSE:CIX – Get Free Report) was downgraded by equities researchers at TD Securities from a “buy” rating to a “sell” rating in a research report issued to clients and investors on Tuesday,BayStreet.CA reports. They presently have a C$32.00 price target on the stock, up from their previous price target of C$28.00. TD Securities’ price objective would indicate a potential upside of 2.99% from the company’s current price.
Several other equities research analysts have also recently weighed in on CIX. Scotiabank boosted their target price on CI Financial from C$25.00 to C$26.00 in a research note on Friday, November 15th. Jefferies Financial Group raised their price objective on shares of CI Financial from C$20.00 to C$27.00 and gave the stock a “buy” rating in a report on Friday, November 1st. Keefe, Bruyette & Woods upped their target price on shares of CI Financial from C$21.00 to C$28.00 in a report on Monday, November 18th. BMO Capital Markets increased their target price on shares of CI Financial from C$22.00 to C$25.00 in a research report on Friday, November 15th. Finally, Raymond James boosted their price target on shares of CI Financial from C$22.00 to C$27.00 in a research report on Friday, November 15th. One analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of C$27.94.
Get Our Latest Research Report on CI Financial
CI Financial Stock Up 0.3 %
About CI Financial
CI Financial Corp. is a publicly owned asset management holding company. Through its subsidiaries, the firm manages separate client focused equity, fixed income, and alternative investments portfolios. It also manages mutual funds, hedge funds, and fund of funds for its clients through its subsidiaries.
See Also
- Five stocks we like better than CI Financial
- Compound Interest and Why It Matters When Investing
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Investing in the High PE Growth Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for CI Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CI Financial and related companies with MarketBeat.com's FREE daily email newsletter.